Overview
What is Kendall & Taylor Atkinson Foundation?
The Kendall & Taylor Atkinson Foundation is a charitable organization established to support investigative work in the medical, scientific, and therapeutic sectors, specifically focusing on Fanconi Anemia and its associated cancers. The organization has earmarked $100,000 for a particular research project named "Gelfitnib/Afatinib Therapy for Head and Neck Squamous Cell Carcinoma," which is currently underway in Littleton, Colorado. The primary objective of the foundation is to raise funds for such charitable allocations, contributing to the advancement of knowledge and treatment options for these conditions.
Official website here: www.katafoundation.org
Is Kendall & Taylor Atkinson Foundation legitimate?
Kendall & Taylor Atkinson Foundation is a legitimate nonprofit organization registered as a 501(c)(3) entity. Kendall & Taylor Atkinson Foundation submitted a form 990, which is a tax form used by tax-exempt organizations in the U.S., indicating its operational transparency and adherence to regulatory requirements. Donations to this organization are tax deductible.
Heare are some key statistics you may want to consider:
Executive Compensation: $0
Professional Fundraising Fees: $0
Other Salaries and Wages: $0
For more financial information, click here
Official website here: www.katafoundation.org
What is the mission statement of Kendall & Taylor Atkinson Foundation?
The Kendall & Taylor Atkinson Foundation is a non-profit organization committed to advancing medical, scientific, and treatment research related to Fanconi Anemia and its associated cancers. Their primary objective is to raise funds for such research initiatives. Currently, they have allocated $100,000 towards a specific study titled "Gelfitnib/Afatinib Therapy for Head and Neck Squamous Cell Carcinoma." The foundation's mission is centered around contributing to the development of potential treatments and understanding of these diseases, ultimately aiming to improve patient outcomes.
Official website here: www.katafoundation.org
Who is the CEO of Kendall & Taylor Atkinson Foundation?
Jeanne Atkinson is the President of Kendall & Taylor Atkinson Foundation.
Official website here: www.katafoundation.org
What is the revenue of Kendall & Taylor Atkinson Foundation?
Kendall & Taylor Atkinson Foundation's revenue in 2022 was $178,816.
Official website here: www.katafoundation.org
Who are the executives of Kendall & Taylor Atkinson Foundation and what are their salaries?
There 35 volunteers at Kendall & Taylor Atkinson Foundation.
Here are 8 key members and their salaries:
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
Official website here: www.katafoundation.org
Where can I find the form 990 for Kendall & Taylor Atkinson Foundation?
Kendall & Taylor Atkinson Foundation's most recent form 990 was submitted in 2022 and can be accessed here.
Official website here: www.katafoundation.org
Learn more at the official website: www.katafoundation.org
Mission Statement of Kendall & Taylor Atkinson Foundation
The Kendall & Taylor Atkinson Foundation is a non-profit organization that is committed to supporting medical, scientific, and treatment research related to Fanconi Anemia and its associated cancers. Their mission is to allocate resources to advance the understanding and treatment of these conditions, with the ultimate goal of improving patient outcomes. Currently, the foundation has funded a research project titled "Gelfitnib/Afatinib Therapy for Head and Neck Squamous Cell Carcinoma" with an investment of $100,000. This initiative underscores the foundation's dedication to backing innovative and potentially life-changing research in the field of oncology.
Shop smarter and support your favorite cause with the Give Freely browser extension. Save money with coupons and donate to charity with a single click. Download now!
Impact
October, 2024
The Kendall & Taylor Atkinson Foundation plays a significant role in advancing research focused on Fanconi Anemia and its associated cancers. By allocating substantial funding, such as the $100,000 grant for the research project "Gelfitnib/Afatinib Therapy for Head and Neck Squamous Cell Carcinoma," the foundation is directly contributing to the scientific understanding and potential treatment of these conditions. This strategic support not only fosters innovation in medical research but also has the potential to improve treatment options and outcomes for patients affected by these serious health issues. Through its commitment to funding critical research initiatives, the foundation amplifies the efforts to combat Fanconi Anemia and related cancers, making a lasting impact in the field of medical science.
This information is meant to be a general summary of Kendall & Taylor Atkinson Foundation. Please take the time to review official sources before making any decisions based upon the content provided here.
Financials
This financial information is from Propublica.
Other financial information:
This information is from the most recently submitted tax form from this organization, which was in 2022.
- Gross Receipts: $250,597
Assets and Liabilities:
- Total Assets: $62,960
- Total Liabilities: $0
- Net Assets: $62,960
Want to help this charity, for free? You can click here to learn more about Give Freely
Organization Details
Founding Year
2006
Phone
(303) 349-1309Principal Officer
Jeanne Atkinson
Main Address
PO BOX 3514, LITTLETON, CO, 801613514
Website
www.katafoundation.orgNTEE Category
Code: T30 - Philanthropy
If you are a representative of Kendall & Taylor Atkinson Foundation and wish to learn more about how Give Freely can help you raise funds, please click here: https://givefreely.com/nonprofits/. Our services are offered at no cost to your organization.